India’s Pharma & Healthcare Market to 2023 – Generic Drugs Account for Around 75% of the Indian Pharmaceutical Market by Volume – ResearchAndMarkets.com
May 24, 2019DUBLIN–(BUSINESS WIRE)–The “India
Pharma and Healthcare Sector Report 2019/2023” report has been
added to ResearchAndMarkets.com’s offering.
This report provides a complete and detailed analysis of the healthcare
and pharmaceutical sector for India . The researcher presents in-depth
business intelligence in a standard format across countries and regions,
providing a balanced mix between analysis and data.
India’s is the world’s 10th-largest pharmaceutical market in US dollar
terms – with sales of over USD 25bn in 2017 – and the largest generic
drug manufacturer and exporter globally. Strong domestic demand and
robust exports have contributed equally to growth in turnover. Generic
drugs account for around 75% of the Indian pharmaceutical market by
volume, as well as most of the drug production in the country.
The Indian pharmaceutical space is highly fragmented, with nearly 10,000
players. The Indian healthcare industry comprises five broad segments –
Healthcare Delivery (Hospitals), Pharmaceuticals, Medical Equipment &
Supplies, and Health Insurance and Diagnostics. Healthcare Delivery
(Hospitals) accounted for nearly 70% of industry revenue in FY2018.
Private hospitals dominate healthcare provision in the country, as
public healthcare services and expenditure are highly inadequate.
What this report allows you to do:
-
Understand the key elements at play in the healthcare and
pharmaceutical sector in India - Access forecasts for growth in the sector
- View key data on healthcare spending and health insurance in India
-
Crystallise the forces both driving and restraining this sector in
India - Build a complete perspective on sector trade, investment and employment
- Understand the competitive landscape and who the major players are
- View M&A activity and major deals
-
Gain an understanding of the regulatory environment for the sector in
India -
Build a clear picture of trends and issues for sub-sectors (medical
institutions, pharmaceuticals manufacturing and distribution channels)
Key Topics Covered
01 EXECUTIVE SUMMARY
- Sector in Numbers
- Sector Overview
- Sector Snapshot
- Driving Forces
- Restraining Forces
02 SECTOR FORECAST
- Macroeconomic Outlook
- Economic Sentiment
- Production and Sales
- Exports
- Imports
03 SECTOR IN FOCUS
- Main Economic Indicators
- Main Sector Indicators
- Health Profile
- Healthcare Expenditure
- Health Insurance
- Global Positioning
- External Trade in Pharmaceuticals
- Pharmaceutical Exports
- Pharmaceutical Imports
- FDI
- Main Events
04 COMPETITIVE LANDSCAPE
- Timeline India Pharma & Healthcare
- Healthcare Highlights
- Healthcare Trends
- Top Hospitals
- Pharmaceutical Highlights
- Top Pharmaceutical Companies
- Medical Device Highlights
- Focus Point – Major Medical Device
- Manufacturing Clusters in India
- M&A Deals
- M&A Activity, January 1, 2016 – December 31, 2018
05 COMPANIES IN FOCUS
- Apollo Hospitals Enterprise Ltd
- Fortis Healthcare Ltd
- Sun Pharmaceutical Industries Ltd
- Lupin Ltd
- Cipla Inc
- Dr. Reddy’s Laboratories
06 REGULATORY ENVIRONMENT
- Government Policy
07 HEALTHCARE SERVICES
- Highlights
- Demand
- Supply
- Medical Tourism
- Telemedicine
08 PHARMACEUTICALS
- Highlights
- External Trade
- Prescription Drugs
- OTC Drugs
- Patented Drugs
- Generic Drugs
- Traditional Medicine
- Clinical Trials
09 MEDICAL DEVICES
- Highlights
- External Trade
- Consumables
- Diagnostic Imaging
- Patient Aids
10 RETAIL CHANNELS
- Brick-and-Mortar Pharmacies
- E-Pharmacies
- Pharmacy Workforce
For more information about this report visit https://www.researchandmarkets.com/r/vac2l
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Healthcare
Services, Pharmaceuticals